Jun 25,2018

Medtronic Receives CE Mark for MiniMed 670G Hybrid Closed Loop System

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité Européenne) Mark for the MiniMed(TM) 670G hybrid closed loop system - the first and only system to automate and personalize the delivery of basal insulin 24 hours a day1. The system is CE Mark approved for the treatment of people with type 1 diabetes 7 years of age and older with ongoing studies to expand the indication to additional patient populations.

REGULATORY CE MARK

#closed loop

View Analyst & Ambassador Comments
Go to original news
Jun 11,2018

Glooko launches diabetes analytics platform

Glooko announced the launch of the new version of its Glooko Web Application platform this morning. The site aims to give users more resources with a streamlined navigation tool and an assortment of diabetes analytics, charts, and graphs.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Jun 13,2018

CMS relents, opens up smartphone-connected CGMs for reimbursement

The Centers for Medicare and Medicaid Services will reverse a longstanding unpopular position on reimbursement for smartphone-connected continuous glucose monitors, CMS announced yesterday.

#cgm

View Analyst & Ambassador Comments
Go to original news
Jun 19,2018

Medtronic, Nutrino partner to bring nutrition info to glucose monitoring app

Medtronic is teaming up with Nutrino, an AI powered personalized nutrition platform. Nutrino’s FoodPrint Report technology will now be integrated into Medtronic’s iPro2 myLog app, a platform that connects with a continuous glucose monitor to help give users insights about their glucose levels. The new technology will enable doctors and clinicians to see the food that a person has logged during their iPro2 cgm evaluation, and will let users see how their bodies react to different foods and will show them the connection between a meal and glucose variability. 

COLLABORATION PARTNERSHIP

#product & service

#mobile app

#cgm

View Analyst & Ambassador Comments
Go to original news
Jun 20,2018

Omada Health expands digital platform with Type 2, hypertension programs, new features

Digital chronic disease management company Omada Health announced today the launch of new programs designed to support individuals with Type 2 diabetes and hypertension. Accompanying these are a set of new features for the enterprise and health plan platform focused on medication adherence and remote monitoring, all of which comprise what a representative from the company described as “the largest product expansion in Omada’s history.”

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 25,2018

Annual diabetes meeting highlights CGMs, artificial pancreases, and other management tech

This weekend saw the kickoff of the American Diabetes Association’s 78th annual conference, and with it a slew of new data from diabetes management players. The meeting included presentation on studies covering a range of technologies, such as continuous glucose monitors, insulin pumps, apps, and other digital-backed management strategies.

View Analyst & Ambassador Comments
Go to original news
Jun 25,2018

Quest Diagnostics reports positive results from diabetes prevention programs, as CMS stalls on those same programs

Working with digital diabetes prevention program (DPP) provider Omada Health — and combining that intervention with lab and biometric screenings — lab company Quest Diagnostics reduced risk for diabetes in one-third of a 107-employee cohort.

CLINICAL STUDY

#dtx

View Analyst & Ambassador Comments
Go to original news
Jun 04,2018

Insulet’s Omnipod® DASH™ Insulin Management System Receives FDA 510(k) Clearance

Insulet Corporation, the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced FDA 510(k) clearance of the Omnipod DASHTM Insulin Management System (Omnipod DASH). This clearance lays the foundation for a steady cadence of innovation that furthers Insulet’s mission to empower users to enjoy simplicity, freedom, and healthier lives with their differentiated technology.

REGULATORY FDA

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jun 05,2018

Changing Health Approved for NHS Funding

NHS England recently announced that Diabetes transformation funded sites are now able to use up to 25% of their 2018/19 structured education allocations for digital self-management applications. Changing Health has been highlighted as a suitable provider for this funding after successfully passing the NHSE technical assessment and being accredited by the independent body, QISMET.

View Analyst & Ambassador Comments
Go to original news
Jun 06,2018

Changing Health Sponsors Diabetes Professional Care Event

Changing Health will be presenting at Diabetes Professional Care 2018, new data to inspire healthcare providers and commissioners, showing how personalised support for behaviour change can be highly effective in diabetes prevention and management, helping patients lose weight, lower their HbA1c and significantly reduce complications. The data supports the need for a new, highly personalised approach to diabetes care outlined in the company’s first White Paper, published in May.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES